Sanford Roger Maris Cancer Center
820 4th St N
Fargo, North Dakota 58102
(701) 234-6161 http://www.sanfordhealth.org kimberly.wold@sanfordhealth.org

Use our guide to learn which trials are right for you!

Sanford Health is an integrated health system headquartered in the Dakotas and is now the largest rural, not-for-profit health care system in the nation with locations in 126 communities in nine states. In addition, Sanford Health is in the process of developing international clinics in Ghana, Israel and Mexico. Sanford Health includes 39 hospitals, 225 clinic locations and 1,360 physicians in 81 specialty areas of medicine. With more than 26,000 employees, Sanford Health is the largest employer in North and South Dakota. The system is experiencing dynamic growth and development in conjunction with nearly a billion dollars in gifts from philanthropist Denny Sanford. These gifts are making possible the implementation of the several initiatives including global children's clinics, multiple research centers and finding a cure for type 1 diabetes and breast cancer.

We've found
40 trials
at this facility
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Cancer Survivor Clinical Trial
Work Ability in Young Adult Cancer Survivors
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase III
Updated: 8/22/2017
mi
from
Fargo, ND
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Concurrent Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Status: Enrolling, Phase II
Updated: 2/2/2016
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 4/7/2016
mi
from
Fargo, ND
Click here to add this to my saved trials
Clinical Trial
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Clinical Trial
Gemcitabine Hydrochloride and Cisplatin in Treating Participants With Invasive Bladder Urothelial Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials